Maxim Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.45 M
- Company Age 26 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.87 Cr
- Revenue Growth 2.32%
- Profit Growth 68.56%
- Ebitda 116.18%
- Net Worth 43.75%
- Total Assets 15.17%
About Maxim Pharmaceuticals
Maxim Pharmaceuticals Private Limited (MPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 December 1998 and has a history of 26 years and one month. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.45 M.
The company has closed loans amounting to ₹3.87 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ashok Dhoka, Manju Dhoka, and Tanvir Mahadik serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239PN1998PTC013106
-
Company No.
013106
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Dec 1998
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Maxim Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Dhoka
|
Managing Director | 10-Dec-1998 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Manju Dhoka
|
Whole-Time Director | 10-Dec-1998 | Current |
|
Tanvir Mahadik
|
Whole-Time Director | 01-Jul-2017 | Current |
Financial Performance of Maxim Pharmaceuticals.
Maxim Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.32% increase. The company also saw a substantial improvement in profitability, with a 68.56% increase in profit. The company's net worth Soared by an impressive increase of 43.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maxim Pharmaceuticals?
In 2022, Maxim Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Madhurhealth And Nutrition Private LimitedAshok Dhoka and Manju Dhoka are mutual person
Charges (Loans)
₹0
₹38.70 M
Charges Breakdown by Lending Institutions
- Corporation Bank : 3.50 Cr
- Central Bak Of India : 0.37 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2009 | Corporation Bank | ₹3.50 Cr | Satisfied |
| 02 Aug 1999 | Central Bak Of India | ₹3.70 M | Satisfied |
How Many Employees Work at Maxim Pharmaceuticals?
Unlock and access historical data on people associated with Maxim Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxim Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxim Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.